Artemisia vulgaris (Labsent) : vertus médicinales en extraction alcoolique

Artemisia vulgaris (Labsent, Absinthe) — famille Asteracées.

Synonymes scientifiques : Absinthium spicatum (Wulfen ex Jacq.) Baumg., Artemisia affinis Hassk., A apetala hort.pest. ex Steud, A cannabifolia H. Lév., A opulenta-Pamp..

Sources externes reconnues associées à cette monographie : Pharmacopée française.

Cette base documente les extractions alcooliques (éthanol) des substances actives. Notre monographie recense actuellement 22 indications en extraction alcoolique pour cette espèce. Le catalogue Lapo v2 enregistre 152 références scientifiques pour cette espèce (détail intégral dans l’application).

Important — références scientifiques sur cette page publique : seuls de courts extraits de chaque source citée sont présentés (phrases d’abstract sélectionnées), conservés dans leur langue d’origine (le plus souvent l’anglais), sans traduction. Ces extraits ne constituent pas le texte intégral de l’article ni une bibliographie complète. Les fiches de référence complètes et le détail monographique sont disponibles dans l’application Lapo v2 (essai gratuit 30 jours).

1. 1

   Cancer traitement adjuvant du cholangiocarcinome et du carcinome hépatique

   Partie usitée : Partie aerienne.

   Références scientifiques (courts extraits)

   Courts extraits uniquement (pas le texte intégral de l’article). Fiches de référence complètes dans l’application Lapo v2.

   • Selon Maki P (2023)

     Extrait The objective was to investigate cytotoxic activity against hepatocellular carcinoma (HepG2), cholangiocarcinoma (KKU-M156) cells of Artemisia Vulgaris Extract, & its compound. It also demonstrated selective cytotoxic activity against liver cancer cells better than cholangiocarcinoma.

   • Selon Sharmila K (2013)

     Extrait The present study pertains to the use of Artemisia vulgaris as a source of anticancer agent. The methanolic extract of the leaves were tested in vitro against HepG2 (hepatocellular carcinoma) cells for their apoptotic properties in synergism with a standard chemotherapeutic drug, etoposide.

   • Selon Vahdati-Mashhadian N (2009)

     Extrait vulgaris against human Caucasian hepatocyte carcinoma (HepG-٢) & human Caucasian larynx carcinoma (Hep-٢) cell lines have been investigated. The cytotoxic effects of these concentrations against two human tumor cell lines, HepG-٢ & Hep-٢ were determined by quantitative MTT assay.

   • Selon Gilani AH (2005)

     Extrait The effect of a crude extract of the aerial parts of Artemisia vulgaris (Av. The hepatoprotective effect was further verified by histopathology of the liver, which showed improved architecture, absence of parenchyma congestion, decreased cellular swelling & apoptotic cells, compared with the findings in the toxin group of animals.

   • Selon Ekiert H (2020)

     Extrait Its herb—Artemisiae vulgaris herba—is used as a raw material due to the presence of essential oil, flavonoids, & sesquiterpenoids lactones & their associated biological activities. Thus far, numerous authors have confirmed the beneficial properties of AV herb extracts, including their antioxidant, hepatoprotective, antispasmolytic, antinociceptive, estrogenic, cytotoxic, antibacterial, & antifungal effects.

2. 2

   Cancer traitement adjuvant du carcinome hépatique

   Partie usitée : Feuille.

   Références scientifiques (courts extraits)

   Courts extraits uniquement (pas le texte intégral de l’article). Fiches de référence complètes dans l’application Lapo v2.

   • Selon Sharmila K (2013)

     Extrait The present study pertains to the use of Artemisia vulgaris as a source of anticancer agent. The methanolic extract of the leaves were tested in vitro against HepG2 (hepatocellular carcinoma) cells for their apoptotic properties in synergism with a standard chemotherapeutic drug, etoposide.

   • Selon Maki P (2023)

     Extrait The objective was to investigate cytotoxic activity against hepatocellular carcinoma (HepG2), cholangiocarcinoma (KKU-M156) cells of Artemisia Vulgaris Extract, & its compound. In regards to NCI criteria which consider that the value of IC50 of a good cytotoxic compound must be less than 4 µg/mL, therefore, it has the potential to be developed as an anti-cancer drug for liver cancer cells.

   • Selon Vahdati-Mashhadian N (2009)

     Extrait vulgaris against human Caucasian hepatocyte carcinoma (HepG-٢) & human Caucasian larynx carcinoma (Hep-٢) cell lines have been investigated. The cytotoxic effects of these concentrations against two human tumor cell lines, HepG-٢ & Hep-٢ were determined by quantitative MTT assay.

   • Selon Al-Yassen A (2022)

     Extrait In this study, the hepatoprotective effect of Iraqi AV against the liver toxic chemotherapy cisplatin were determined in mice. Artemisia vulgaris L.

   • Selon Gilani AH (2005)

     Extrait The hepatoprotective effect was further verified by histopathology of the liver, which showed improved architecture, absence of parenchyma congestion, decreased cellular swelling & apoptotic cells, compared with the findings in the toxin group of animals. The effect of a crude extract of the aerial parts of Artemisia vulgaris (Av.

3. 3

   Diabete mellitus de type II

   Partie usitée : Partie aerienne. Profil pharmacologique documenté : Acarbose-like.

   Références scientifiques (courts extraits)

   Courts extraits uniquement (pas le texte intégral de l’article). Fiches de référence complètes dans l’application Lapo v2.

   • Selon Neagu E (2023)

     Extrait this work analyzed the antidiabetic & anti-inflammatory potential of Artemisia absinthium, Artemisia vulgaris & Trigonella foenum-graecum herbs, which have been studied less from this point of view. vulgaris; & genistin in T.FG The antidiabetic activity of the extracts was analyzed by testing their ability to inhibit α-amylase & α-glucosidase, & the anti-inflammatory activity was analyzed by testing their ability to inhibit hyaluronidase & lipoxygenase.

   • Selon Hussain LG (2024)

     Extrait That is why the aim of the current study was to determine the left ventricular remodeling potential of the methanolic extract of Artemisia vulgaris in a diabetic cardiomyopathy rat model. Artemisia vulgaris treatment significantly (p ≤ 0.05) reduced fasting blood glucose (108.5 ± 1.75 mg/dL), glycated hemoglobin (4.03 ± 0.12 %), serum glucose (116.66 ± 3.28 mg/dL), insulin (15.66 ± 0.66 ng/mL), total oxidant status (54.66 ± 3.22 µmol H2O2Equiv.L−1), Malondialdehyde (0.20 ± 0.01 mmol/L), total cholesterol (91.16 ± 3.35 mg/dL), triglycerides (130.66 ± 3.15 mg/dL), low-density lipids (36.57 ± 1.02 mg/dL), sodium (140 ± 3.21 mmol/L), calcium (10.44 ± 0.24 mmol/L), creatine kinase MB (1227.5 ± 17.89 IU/L), lactate dehydrogenase (1300 ± 34.64 IU/L), C-reactive protein (30 ± 0.57 pg/mL), tumor necrosis factor-α (58.66 ± 1.76 pg/mL), atrial natriuretic peptide (2.53 ± 0.04 pg/mL), B-type natriuretic peptide (10.66 ± 0.44 pg/mL), aspartate aminotransferase (86.5 ± 4.99 U/L), Alanine Transaminase (55.33 ± 2.90 U/L), urea (25.33 ± 1.15 mg/dL) & creatinine (0.64 ± 0.02 mg/dL) but significantly increased (p ≤ 0.05) total antioxidant capacity (1.73 ± 0.07 mmol Trolox Equil./L), high-density lipids (40 ± 1.59 mg/dL) & potassium (3.82 ± 0.04 mmol/L) levels.

   • Selon Hussain M (2024)

     Extrait It is in this context, the present review aims to provide a comprehensive account of the traditional uses, phytochemistry, documented biological properties & toxicity of all the species of Artemisia & offers useful insights for practitioners & researchers into underutilized species & their potential applications. Artemisia species have a rich history in traditional medicine worldwide, offering remedies for a wide range of ailments, such as malaria, jaundice, toothache, gastrointestinal problems, wounds, inflammatory diseases, diarrhoea, menstrual pains, skin disorders, headache, & intestinal parasites.

   • Selon TAVARES WR (2025)

     Extrait Metabolic syndrome, a cluster of metabolic disorders comprising dyslipidemia, insulin resistance, elevated blood pressure, & abdominal obesity, is a silent epidemic that may lead to outcomes such as cardiovascular disease, diabetes, & cancer. Regarding clinical trials concerning Artemisia, there are more studies aiming to see its effect on diabetes, but the studies about cancer are more advanced.

D’autres indications (y compris d’autres modes d’extraction le cas échéant), posologies, précautions d’emploi et les <strong>références scientifiques complètes</strong> (fiches intégrales, pas seulement les courts extraits ci-dessus) sont disponibles dans la fiche monographique de l’application Lapo v2.